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Abstract A His-tagged full-length cDNA of human mitochon-
drial leucyl-tRNA synthetase was expressed in a baculovirus
system. The N-terminal sequence of the enzyme isolated from
the mitochondria of insect cells was found to be IYSATGKWT-
KEYTL, indicating that the mitochondrial targeting signal pep-
tide was cleaved between Ser39 and Ile40 after the enzyme
precursor was translocated into mitochondria. The enzyme pu-
ri¢ed from mitochondria catalyzed the leucylation of Escheri-
chia coli tRNALeu1 (CAG) and Aquifex aeolicus tRNA
Leu(GAG)
with higher catalytic activity in the leucylation of E. coli
tRNALeu than that previously expressed in E. coli without the
N-terminal 21 residues.
4 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Aminoacyl-tRNA synthetases (aaRSs) play a key role in
protein biosynthesis. They catalyze the esteri¢cation of amino
acids to the 2P- or 3P-hydroxyl group of ribose at the 3P-end of
their cognate tRNAs [1,2]. These aaRSs can be divided into
Class I and Class II with 10 members in each class according
to their conserved sequences and characteristic structural mo-
tifs [3]. Leucyl-tRNA synthetase (LeuRS) belongs to Class I,
which is characterized by two structural motifs (HIGH and
KMSKS) [3]. LeuRS functions to leucylate its cognate tRNA
[3], but in some cases it has been shown to mischarge the
leucine cognate tRNA with other amino acids in vitro and
in vivo [4]. In addition, in vitro, some mutated Escherichia
coli tRNALeu can be more easily mischarged by E. coli LeuRS
than the native tRNALeu (unpublished data of our lab).
The cDNA of human mitochondrial leucyl-tRNA synthe-
tase (hmLeuRS) was isolated from an immature myeloid
cDNA library and shown to be present in 16 di¡erent human
tissues [5]. When the cDNA sequence of hmLeuRS was
BLASTed with the human genome database, the 22-exon
gene was found to be located on chromosome 3p21. Bullard
et al. predicted that this enzyme would be targeted into mi-
tochondria and the mitochondrial signal peptide was cleaved
after Gly21. The predicted hmLeuRS cDNA was expressed
and analyzed in E. coli [6]. However, our work here showed
that the signal peptide of hmLeuRS was cleaved between
Ser39 and Ile40. The direct evidence of the localization of
hmLeuRS in mitochondria will be also presented.
This ¢nding is interesting as many neuromuscular disorders
are associated with the mutation of mitochondrial tRNA
genes [7]. The human mitochondrial tRNALeu(UUR)
(hmtRNALeu(UUR)) gene is one of the most frequently mu-
tated genes [8]. The mutations have been associated with mi-
tochondrial encephalomyopathies, mitochondrial myopathy,
encephalopathy, lactic acidosis and stroke-like episodes
(MELAS) [8]. A single replacement of A3243 by G was
most frequently found in hmtRNALeu(UUR) mutation related
to MELAS [9]. Therefore, further studies on hmLeuRS may
lead to better understanding of the mechanisms of
hmtRNALeu mutation-related diseases.
Here, we report the cloning of the His-tagged full-length
cDNA of hmLeuRS into baculovirus and its expression in
Trichoplusia ni BTI-Tn-5B1-4 (Tn5) insect cells. The processed
hmLeuRS was puri¢ed from the insect mitochondria to over
95% homogeneity, and its N-terminal sequence and kinetic
constants were determined.
2. Materials and methods
2.1. Chemicals, plasmids, and insect cell line
All chemicals were purchased from Sigma, except otherwise noted.
Kinase, ligase, and restriction endonucleases were obtained from New
England Biolabs. The Bac-to-Bac baculovirus expression systems in-
cluding plasmid pFastBac1, MAX EFFENCY DH10BAC competent
cells, insect cell Tn5, and Sf-900 II serum-free medium (containing L-
glutamine) were purchased from Gibco/BRL (Life technologies, Inc.).
The hmLeuRS expressed in E. coli with the deletion of N-terminal 21
residues (called hmLeuRS-22), was puri¢ed as described by Bullard et
al. [6]. E. coli tRNALeu1 (CAG) (1066 pmol/A260) and Aquifex aeolicus
tRNALeu(GAG) (900 pmol/A260) were isolated in our lab [10,11].
2.2. Construction of recombinant baculovirus containing hmLeuRS gene
(hmleus) and the expression of hmLeuRS in insect cell Tn5
Two complementary oligonucleotides 5P-GGCCGCGCACCATCA-
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TCACCACCATTAGGTAC-3P and 5P-CTAATGGTGGTGATGA-
TGGTGCGC-3P (encoding Ala3-His6-Stop) were phosphorylated, an-
nealed and inserted between the NotI and KpnI sites of the pFastBac1
vector to create pFastBac1H. The full-length cDNA of hmLeuRS
without stop codon was polymerase chain reaction (PCR) ampli¢ed
from pBluescript SKþ vectors containing hmleus (KIAA-0028, acces-
sion number D21851, gifted from the Kazusa DNA Research Insti-
tute, Japan). The PCR product was inserted between the SalI and
NotI sites of pFastBac1H to create pFastBac1H-hmleus, from which
the expressed hmLeuRS would be Ala3-His6-tagged at its C-terminus.
The sequence of pFastBac1H-hmleus was con¢rmed by DNA sequenc-
ing. pFastBac1H-hmleus was used to prepare hmleus-recombinant
bacmid DNA according to the manufacturer’s instructions for Bac-
to-Bac baculovirus expression systems. The recombinant bacmid
DNA was then used to transfect Tn5 insect cells, which were grown
in Sf-900 II serum-free medium (containing L-glutamine) to express
hmLeuRS. The enzyme expressed in the baculovirus system was
named hmLeuRS-B.
2.3. Puri¢cation of hmLeuRS-B
After 4 days, the cells expressing hmLeuRS-B were collected by
centrifugation at 500Ug and washed in phosphate-bu¡ered saline
(pH 7.5). The mitochondria, cytoplasm and nuclei/cellular debris
were separated [12,13] and hmLeuRS-B was puri¢ed from mitochon-
dria with Ni-NTA column chromatography according to the manu-
facturer’s protocol (Qiagen, Germany).
2.4. Determination of N-terminal sequence of hmLeuRS-B
The hmLeuRS-B puri¢ed from the mitochondria of Tn5 insect cells
was separated by 10% sodium dodecyl sulfate^polyacrylamide gel
electrophoresis (SDS^PAGE), transferred to polyvinylidene di£uoride
membrane (PVDF, ProBlott1, Applied Biosystems, USA), and the
¢rst 14 amino acid residues at the N-terminal end were sequenced
with protein sequencer 477A (Applied Biosystems) according to the
manufacturer’s instructions.
2.5. Localization of hmLeuRS-B in subcellular fractions using Western
blot
Nuclei/cellular debris, cytoplasm and mitochondria were separated
as mentioned above. The quality of subcellular fractions was con-
trolled by determining succinate dehydrogenase activity as described
[12,13]. The subcellular fractions were analyzed by SDS^PAGE, blot-
ted to nitrocellulose membranes (Bio-Rad, USA). The His-tagged
hmLeuRS-B was detected by 0.1 Wg/ml monoclonal mouse anti-His-
tag antibody and 0.5 Wg/ml peroxidase-conjugated goat anti-mouse
antibody. The blotting was visualized using the SuperSignal West
Pico Chemiluminescence method (Pierce, Inc.)
2.6. Determination of kinetic constants
Activities and kinetic constants in ATP-PPi exchange and tRNALeu
leucylation were measured at 37‡C as described by Bullard et al. [6].
One unit of ATP-PPi exchange activity was de¢ned as the amount of
enzyme that catalyzed 1 nmol ATP-PPi exchange in 1 min at 37‡C.
One unit of leucylation activity was de¢ned as the amount of enzyme
needed to catalyze the production of 1 nmol leucyl-tRNA in 1 min at
37‡C. Kinetic constants of hmLeuRS were determined using di¡erent
concentrations of the substrates. Protein concentrations were deter-
mined by the Lowry method [14,15].
2.7. Fluorescence spectroscopy
Fluorescence spectra were recorded with a Hitachi F4010 £uores-
cence spectrophotometer (Japan). hmLeuRS-22 was measured in par-
allel with hmLeuRS-B to ¢nd subtle di¡erence in their structures. The
emission spectra in 20 mM potassium phosphate bu¡er (pH 7.5) ex-
cited at 295 nm (slit width 20 nm) were recorded in the range of 320^
400 nm (slit width 5 nm). The protein concentration was 10 Wg/ml.
3. Results and discussion
3.1. Expression and puri¢cation of hmLeuRS-B
Recombinant baculovirus vectors have been widely used to
express heterologous genes in cultured insect cells. In most
cases, the recombinant proteins will be processed, and tar-
geted to their appropriate cellular locations [16]. The pFast-
Bac1 vector provided with the Bac-to-Bac baculovirus expres-
sion system does not o¡er a C-terminal His-tag needed for
puri¢cation and detection of hmLeuRS-B. Therefore, we con-
structed a new vector to express the hmLeuRS with a C-ter-
minal His-tag.
From the mitochondria prepared from 1.6U108 insect cells,
about 120 Wg of puri¢ed hmLeuRS-B was obtained by Ni-
NTA a⁄nity chromatography. The puri¢ed hmLeuRS-B
was over 95% homogeneous and its molecular mass was about
97 kDa as determined by SDS^PAGE (Fig. 1A, lane 2).
3.2. Localization of hmLeuRS-B in vivo
The localization of hmLeuRS in vivo was not determined
previously [6], so we investigated the location of hmLeuRS-B
in Tn5 cells in the present work. Lysates of insect cells ex-
pressing hmLeuRS-B were fractionated into three fractions:
nuclei/cellular debris, cytoplasm, and mitochondria. Succinate
dehydrogenase activity is found only in mitochondria [13]. In
the present work, a high activity of succinate dehydrogenase
was found in the mitochondrial fraction, as compared to the
nuclei/cellular debris fraction or the cytoplasm fraction (Table
1). Western blot revealed that the hmLeuRS-B band was
present in the mitochondrial fraction, but completely absent
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Fig. 1. SDS^PAGE analysis of puri¢ed hmLeuRS-B (A) and West-
ern blotting of subcellular fractions from insect cells expressing
hmLeuRS-B (B). A: Puri¢ed hmLeuRS-B (lane 2, 3 Wg) was com-
pared to protein standards (lane 1). B: hmLeuRS-B was present in
the mitochondrial (lane 2, 10 Wg) and nuclei/cellular debris fractions
(lane 4, 40 Wg in order to show trace uncleaved precursor of
hmLeuRS-B), while completely absent from cytoplasmic fraction
(lane 3, 10 Wg). Puri¢ed hmLeuRS-B (lane 1, 3 Wg) was used as a
control.
Table 1
Subcellular fractions of insect cells expressing hmLeuRS-B
Succinate dehydrogenase Nuclei/cellular debris Cytoplasm Mitochondria
Units/(1U107 cells)a 0.434 0 2.05
% units of total 17.4 0b 82.0
All data in this table were the average values with a variation of 6 5% from three independent determinations.
aUnits =Abs490/min.
b6 1%.
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from the cytoplasmic fraction (Fig. 1B, lanes 2 and 3). This
result showed that the expression product of hmleus gene was
translocated into mitochondria in vivo, providing the ¢rst
direct evidence of the mitochondria localization of this en-
zyme. Two bands were observed in the nuclei/cellular debris
fraction (Fig. 1B, lane 4): one strong band corresponding to
hmLeuRS-B, apparently because of the contamination by in-
tact insect cells, and another weaker band above hmLeuRS-B
that may be the uncleaved enzyme containing the mitochon-
drial signal peptide not yet translocated into mitochondria.
3.3. Mitochondrial import signal peptide of hmLeuRS-B
The cleaved site of the signal peptide of hmLeuRS-B was
determined by amino acid sequencing. The sequence of the
¢rst 14 amino acid residues was determined as IYSATG-
KWTKEYTL, showing that the signal peptide was cleaved
between Ser39 and Ile40. The calculated molecular mass of
hmLeuRS-B is 98533.51 Da that approximates to the molec-
ular mass determined by SDS^PAGE (Fig. 1A). The N-termi-
nal sequences of LeuRSs from di¡erent sources are aligned in
Fig. 2. The processed N-terminal sequence of hmLeuRS-B is
very close to that of yeast mitochondrial LeuRS (Fig. 2) [19].
Analysis of the full-length cDNA of hmLeuRS using the pre-
dicted amino acid sequence program PSORT indicated that
the cleavage of the signal peptide would occur after Gly21 [6].
The di¡erence between the predicted and the expressed ma-
ture form in insect cells is most likely due to a miscalculation
by the prediction program. Previous expression of mitochon-
drial proteins in the baculovirus system indicated that the
processing of human mitochondria-targeted proteins in bacu-
lovirus expression systems was correct [21^23].
3.4. Comparison of the £uorescence emission spectra of
hmLeuRS-B and hmLeuRS-22
To investigate the subtle conformational di¡erences of
hmLeuRS-B and hmLeuRS-22, £uorescence emission spectra
were determined. The V emission of hmLeuRS-B (338.2 nm)
was blue shifted slightly in comparison with that of
hmLeuRS-22 (338.8 nm), indicating that hmLeuRS-22 has a
looser conformation and less hydrophobic regions.
3.5. Activity assay of hmLeuRS-B
The kinetic constants of hmLeuRS-B in the ATP-PPi ex-
change and leucylation reactions are summarized in Table 2.
In the ATP-PPi exchange reaction, kcat of hmLeuRS-B is 0.14
s31, which is lower than that of prokaryotic (E. coli 171 s31
[24], and A. aeolicus 4.0 s31 [11]), eukaryote cytoplasmic (Pha-
seolus vulgaris 16 s31 [25]) and plant chloroplastic LeuRSs (P.
vulgaris 8 s31 [25]). The Km of hmLeuRS-B for leucine is 250
WM, which is larger than that of E. coli LeuRS (52 WM [24])
and A. aeolicus LeuRS (3.5 WM [11]). However, the Km for
ATP is 127 WM, which is smaller than that of E. coli LeuRS
(750 WM [24]) and A. aeolicus LeuRS (360 WM [11]). These
results suggest that in the ATP-PPi exchange reaction,
Fig. 2. Alignment of N-terminal sequences of LeuRSs from seven
sources. The sequences of LeuRSs from Homo sapiens mitochondria
(Hsm), S. cerevisiae mitochondria (Scm), Neurospora crassa mito-
chondria (Ncm), E. coli (Ec), Rickettsia prowazekii (R), A. aeolicus
(Aa) and S. cerevisiae cytoplasm (Scc) were downloaded from
aaRSs database (http://rose.man.poznan.pl/aars/) [17] and aligned by
CLUSTAL W [18]. The shadowed sequences represent the cleaved
signal peptides of LeuRSs of H. sapiens mitochondria, S. cerevisiae
mitochondria [19], N. crassa mitochondria [20]. C represents the
consensus sequence of these seven LeuRSs.
Table 2
Kinetic constants for hmLeuRS-B at 37‡Ca
Substrates Constants ATP-PPi exchange reactionb Leucylation of tRNALeu reactionc
Leucine Km (WM) 250 39.7
kcat (s31) 0.14 5.3U1032
kcat/Km (s31 WM31) 5.6U1034 1.33U1033
ATP Km (WM) 127 1192
kcat (s31) 0.13 4.9U1032
kcat/Km (s31 WM31) 1.0U1033 4.1U1035
E. coli tRNALeu1 Km (WM) 2.2
kcat (s31) 4.1U1032
kcat/Km (s31 WM31) 1.85U1032
A. aeolicus tRNALeu Km (WM) 2.8
kcat (s31) 1.9U1032
kcat/Km (s31 WM31) 0.68U1032
aThe experiments were performed as described in Section 2. All data in this table were the average values with a variation of 6 5% from three
independent determinations.
bThe speci¢c activity of hmLeuRS-B in ATP-PPi exchange reaction was 83 units/mg, as calculated from the molecular mass (98.5 kDa) and
average kcat of leucine and ATP.
cThe speci¢c activity of hmLeuRS-B in the leucylation of tRNA reaction was 29 units/mg, calculated from the molecular mass (98.5 kDa) and
average kcat of leucine, ATP and E. coli tRNALeu1 . The kinetics of leucine and ATP in leucylation of tRNA
Leu reaction was measured in pres-
ence of 20 WM of E. coli tRNALeu1 .
FEBS 26877 3-1-03
Y.-N. Yao et al./FEBS Letters 534 (2003) 139^142 141
hmLeuRS-B binds leucine rather weakly, but binds ATP
tightly as compared to E. coli and A. aeolicus LeuRSs.
In the leucylation reaction, for the three substrates of
hmLeuRS-B (E. coli tRNALeu1 used in the assay), the kcat
value of hmLeuRS-B is 4.8 U 0.5U1032 s31, about 3-fold low-
er than that in the ATP-PPi exchange reaction. This value is
rather low as compared with that of E. coli LeuRS (3.3 s31)
[24], A. aeolicus LeuRS (0.39 s31) [11], P. vulgaris cytoplasmic
LeuRS (2.05 s31) [25], Saccharomyces cerevisiae cytoplasmic
LeuRS (3.3 s31) [26], plant P. vulgaris chloroplastic LeuRS
(3.15 s31) [27], and Euglena gracilis chloroplastic LeuRS
(2 s31) [28]. The Km values for leucine and ATP were 40
and 1192 WM, respectively. In comparison with the ATP-PPi
exchange reaction, these results suggest that hmLeuRS-B
binds leucine more tightly, but binds ATP only weakly. The
Km of hmLeuRS-B for leucine is 2.7- and 6.3-fold higher than
that of E. coli and A. aeolicus LeuRSs respectively; that for
ATP is 4.25- and 2.16-fold higher, respectively [11,24]. These
results show that hmLeuRS-B catalyzes the ATP-PPi ex-
change and leucylation reactions at a lower rate and binds
with its three substrates weakly. Other eukaryotic mitochon-
drial aaRSs have been found to have lower catalytic activity
than their cognate cytoplasmic and prokaryotic aaRSs
[12,29,30]. Our present work is in agreement with these re-
ports.
The hmLeuRS-B can catalyze the leucylation of E. coli
tRNALeu1 and A. aeolicus tRNA
Leu at a lower rate, and the
Km values for E. coli and A. aeolicus tRNALeus are similar,
indicating that hmLeuRS-B recognizes the two bacterial
tRNALeus with similar a⁄nity. This result also suggests
some evolutionary conservation of catalytic elements for
tRNALeus in hmLeuRS. The catalytic e⁄ciency of hmLeuRS
is lower than that observed in the leucylation reaction cata-
lyzed by E. coli LeuRS [11,24]. It can be postulated that
hmLeuRS catalyzes the leucylation of the natural hmtRNALeu
with higher e⁄ciency than that of bacterial tRNALeus. We
cloned the mitochondrial genes encoding the two hmtRNALeu
isoacceptors, but were unable to express the genes in E. coli.
The mature hmLeuRS-B in insect cells has higher speci¢c
leucylation activity (29 units/mg) than hmLeuRS-22 expressed
in E. coli (3.3 units/mg) [6]. The reason for this may be that
the maturation process of mitochondrial proteins in insect
cells, such as N-terminal cleavage, refolding of mitochon-
dria-imported proteins and potential modi¢cation of amino
acid residues, is more suitable for the processing of human
mitochondrial proteins in vivo [31]. The more rigid struc-
ture of Tn5-derived hmLeuRS-B observed in £uorescence
spectra might be the result of such processing. The relative
high catalytic e⁄ciency of hmLeuRS-B may be used to inves-
tigate the leucylation and mis-aminoacylation properties of
mutant hmtRNALeu associated with human mitochondrial
diseases.
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